COMPARATIVE EXAMINATION OF BIOCHEMICAL DEVIATIONS IN PATIENTS WITH DIABETES WHO HAVE CARDIOVASCULAR COMPLICATIONS OR NOT
Main Article Content
Keywords
Biochemical parameters, cardiovascular disease, Diabetes Mellitus, Cholesterol, Dyslipidemia
Abstract
Objectives: To evaluate the relationship between blood glucose levels and lipid profiles in diabetic individuals with and without cardiac disease.
Study Design: A Cross-sectional Study
Place and duration of study: Department of Diabetes & Endocrinology & Cardiology HMC Hospital Peshawar from 11 Jan 2022 to 11 July 2022
Methodology: For the study, 90 people were split up into comparative groups. Diabetes patients were divided into cardiac and non-cardiac groups. A questionnaire was used to gather demographic information, and a physical examination was used to document clinical data. Every patient had blood drawn for further lipid profile and glycemic tests. Data analysis was done using SPSS version 28.
Results: The average age of diabetic patients with cardiac problems (n = 45) was substantially more significant than that of patients without (44.49 ± 10.22 years), at 52.36 ± 09.77 years. The two groups showed markedly reduced HDL-C levels and higher total cholesterol, LDL-C, and glucose levels, suggesting a robust relationship between biochemical indicators and cardiovascular problems in diabetes.
Conclusion: The study's findings show a substantial correlation between biochemical markers and cardiovascular illness in individuals with diabetes. Hyperlipidemia is more common in those with diabetes.
References
2. Patil SR, Chavan AB, Patel AM, Chavan PD, Bhopale JV. A Review of Diabetes Mellitus's Types, Pathophysiology, Epidemiology, and Global Burden. Journal for Research in Applied Sciences and Biotechnology. 2023 Aug 14;2(4):73-9.
3. Bobga Billa JK. Challenges and opportunities in managing Type 2 Diabetes Mellitus in Sub-Saharan Africa: the cases of Nigeria and South Africa (Doctoral dissertation, Hochschule für Angewandte Wissenschaften Hamburg).
4. Sebastian SA, Co EL, Kanagala SG, Padda I, Sethi Y, Johal G. Metabolic Surgery in Improving Arterial Health in Obese Individuals. Current Problems in Cardiology. 2023 Dec 20:102359.
5. Batta A, Hatwal J, Batta A, Verma S, Sharma YP. Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship. World Journal of Cardiology. 2023 May 5;15(5):229.
6. Jyotsna FN, Ahmed A, Kumar K, Kaur P, Chaudhary MH, Kumar S, Khan E, Khanam B, Shah SU, Varrassi G, Khatri M. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023 Aug 21;15(8).
7. Alanazi N, Alruwaili Y, Alazmi A, Alazmi A, Alanazi M, Alruwaili W. A Systematic Review of Machine Learning and Artificial Intelligence for Diabetes Care. Journal of Health Informatics in Developing Countries. 2023 May 7;17(01).
8. Ali MR, Nacer H, Lawson CA, Khunti K. Racial and ethnic disparities in primary prevention of cardiovascular disease. Canadian Journal of Cardiology. 2024 Feb 2. Dec 22:11245.
9. Vekic J, Stefanovic A, Zeljkovic A. Obesity and dyslipidemia: a review of current evidence. Current Obesity Reports. 2023 Sep;12(3):207-22.
10. Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Peña Genao E, Guzman E, Kostara CE. The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio is a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics. 2023 Mar 1;13(5):929.
11. Alkubaisi MR, Tahir NT, Abdilya R. Dyslipidemia poses a significant risk of many complications for Type 2 Diabetes Mellitus Patients: Article Review. NTU Journal of Pure Sciences. 2023 Sep 30;2(3).
12. Vig H, Ap R, Vishwas HN, Tyagi S, Rathore S, Wal A, Wal P. An Insight into the Pathogenesis of Diabetic Cardiomyopathy and the Novel Potential Therapeutic Approaches. Current Diabetes Reviews. 2024 Jan 1;20(1):120-34.
13. Ahmad MM, Bukhari SA, Chaudhary Z, Khalid SH, Amin H. ASSOCIATION OF METABOLIC SYNDROMES AND BIOCHEMICAL MARKERS FOR THE PROGRESSION OF NONALCOHOLIC FATTY ACID DISEASE. Journal of Population Therapeutics and Clinical Pharmacology. 2023 Sep 30;30(17):2275-87.
14. Komai H, Ogura M, Sakashita H, Miyama N, Yamamoto N, Takai K, Hatada A, Tanimura N, Nakamura T, Yoshida M, Kawaura T. The real-world data of lipid-lowering treatment in patients with peripheral artery disease and its association with disease severity. Journal of Cardiology. 2023 Oct 9.
15. Sobolewska-Nowak J, Wachowska K, Nowak A, Orzechowska A, Szulc A, Płaza O, Gałecki P. Exploring the heart–mind connection: unraveling the shared pathways between depression and cardiovascular diseases. Biomedicines. 2023 Jul 5;11(7):1903.
16. Chen J, Arshi B, Waqas K, Lu T, Bos D, Ikram MA, Uitterlinden AG, Kavousi M, Zillikens MC. Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study. Cardiovascular Diabetology. 2023 Nov 28;22(1):326.
17. Liu Y, Zou X, Zhao W, Yao X, Wang L, Zhou L, Zhang R, Luo Y, Li M, Zhang X, Zhu Y. Adrenal limb thickness is associated with metabolism profiles in patients with diabetes: A cross‐sectional study. Journal of Diabetes. 2023 Sep 26.
18. Feingold KR, Grunfeld C. Diabetes and dyslipidemia. InDiabetes and Cardiovascular Disease 2023 Jun 2 (pp. 425-472). Cham: Springer International Publishing.
19. An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, Jiang ZZ. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovascular Diabetology. 2023 Sep 2;22(1):237.
20. Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, Kashif M, Shahzeen F, Tayyab A, moazzam Khan MS, Junejo M. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023 Sep 24;15(9).
21. Jyotsna FN, Ahmed A, Kumar K, Kaur P, Chaudhary MH, Kumar S, Khan E, Khanam B, Shah SU, Varrassi G, Khatri M. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Muhammad Hussain Afridi
Assistant professor Diabetes and endocrinology Hayatabad Medical Complex Peshawar
Cheragh Hussain
Associate Professor Department of Cardiology HMC Peshawar
Khalid Usman
Post graduate trainee endocrinology Hayatabad Medical Complex Peshawar
Shaista Kawanl
Consultant Diabetes and endocrinology Hayatabad Medical Complex Peshawar